(Q42982060)

12 November 2017

5 references

21 March 2019

2 October 2019

7 October 2019

11 October 2019

11 October 2020

Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease? (English)

1 reference

inflammatory bowel diseases

12 November 2017

5 references

21 March 2019

2 October 2019

7 October 2019

11 October 2019

11 October 2020

1 reference

2 October 2019

human digestive system

1 reference

7 October 2019

1 reference

11 October 2019

1 reference

11 October 2020

Kruidenier L

1

1 reference

PMC publication ID

1781836

12 November 2017

Verspaget HW

series ordinal

2

1 reference

12 November 2017

1 January 1998

1 reference

Mediators of Inflammation

12 November 2017

6 references

12 November 2017

21 March 2019

2 October 2019

7 October 2019

11 October 2019

11 October 2020

7

1 reference

12 November 2017

3

1 reference

12 November 2017

157-162

1 reference

Creative Commons Attribution 3.0 Unported

12 November 2017

start time

1 January 1998

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Short-chain fatty acids in ulcerative colitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781836

Nutrition and ulcerative colitis

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781836

Modulation of inflammation and cytokine production by dietary (n-3) fatty acids

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781836

Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781836

The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781836

A stable nitroxide radical effectively decreases mucosal damage in experimental colitis

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781836

Role of reactive oxygen metabolites in experimental colitis

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781836

Medical management of severe inflammatory disease of the rectum and distal colon: non-nutritional aspects

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781836

Role of oxygen free radicals in the etiology of pouchitis

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781836

Mitomycin C-induced colitis in rats: a new animal model of acute colonic inflammation implicating reactive oxygen species

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781836

Agents capable of eliminating reactive oxygen species. Catalase, WR-2721, or Cu(II)2(3,5-DIPS)4 decrease experimental colitis

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781836

Impairment of antioxidants in colonic epithelial cells isolated from trinitrobenzene sulphonic acid-induced colitis rats. Protective effect of rebamipide

26 May 2018

1 reference

12 December 2020

Effect of lecithinized-superoxide dismutase on the rat colitis model induced by dextran sulfate sodium

1 reference

12 December 2020

Effect of Z-103 on TNB-induced colitis in rats

1 reference

12 December 2020

Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study

1 reference

12 December 2020

Phase II trial of copper zinc superoxide dismutase (CuZnSOD) in treatment of Crohn's disease

1 reference

12 December 2020

Role of oxygen-derived free radical scavengers in the management of recurrent attacks of ulcerative colitis: a new approach

1 reference

12 December 2020

Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease

1 reference

12 December 2020

Identifiers

DOI

10.1080/09629359891081

1 reference

12 November 2017

1 reference

PMC publication ID

1781836

12 November 2017

PubMed publication ID

9705602

1 reference

PMC publication ID

1781836